We investigated the hematologic abnormalities and prognoses in 16 cats with
myelodysplastic syndromes (MDS). Nonregenerative anemia, thrombocytopenia,
and neutropenia were observed in 15, 13, and 4, respectively, of the 16 ca
ts with MDS. Morphologic abnormalities characteristic of MDS included megal
oblastoid rubricytes (9 cats), hyposegmentation of neutrophils (7 cats). nu
clear abnormality of rubricytes (10 cats) and neutrophils (13 cats), and mi
cromegakaryocytes (10 cats). Disease in these 16 cats was subclassified int
o refractory anemia (RA; 8 cats), RA with excess of blasts (RAEB; 5 cats),
RAEB in transformation (RAEB in T, 1 cat), and chronic myelomonocytic leuke
mia (CMMoL 2 cats), according to the human French-American-British (FAB) cl
assification. In the cats in which the clinical outcome was known. 3 of 6 c
ats with high blast cell count MDS, including RAEB, RAEB in T and CMMoL. de
veloped acute myeloid leukemia, but only I of 8 cats with low blast cell co
unt MDS (RA) developed acute myeloid leukemia. Based on the Dusseldorf scor
ing system for the prognosis of human MDS, the survival times of the cats s
howing high scores (greater than or equal to3 points) were significantly sh
orter than those of the cats with low scores (<3 points). The FAB classific
ation and Dusseldorf scoring system were considered to be useful for predic
ting the prognosis of feline MDS. Furthermore, 15 of the 16 cats with MDS i
n this study were infected with feline leukemia virus, indicating its possi
ble etiologic role in the pathogenesis of feline MDS.